Short-term nicotine replacement therapy (NRT) has helped many smokers to quit, but many continue to use nicotine replacement products for longer than the recommended 12 to 14 weeks of treatment as they struggle to remain abstinent. But there are limited data on the safety and efficacy of such long-term use, creating a challenge for policy makers such as the US Food and Drug Administration (FDA).
Currently, the FDA has approved the use of NRT products for short-term use only. To begin assessing the data on long-term NRT use and the need for such an indication, the agency convened a workshop on October 27.
Graphic Jump Location
Data are limited on the safety and efficacy of long-term use of nicotine replacement products beyond 12 to 14 weeks of treatment.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.